Aeterna Zentaris Company Insiders
| AEZS Stock | USD 1.97 0.01 0.51% |
Aeterna Zentaris employs about 29 people. The company is managed by 29 executives with a total tenure of roughly 216 years, averaging almost 7.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Aeterna Zentaris' management performance can provide insight into the firm performance.
| Michael Ward CEO CEO |
| David Dodd Chairman Chairman, CEO and Pres |
Aeterna |
Aeterna Zentaris Management Team Effectiveness
The company has return on total asset (ROA) of (0.2419) % which means that it has lost $0.2419 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6134) %, meaning that it created substantial loss on money invested by shareholders. Aeterna Zentaris' management efficiency ratios could be used to measure how well Aeterna Zentaris manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.48 in 2024. Return On Capital Employed is likely to drop to -0.6 in 2024. At this time, Aeterna Zentaris' Total Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 53.4 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 613.4 K in 2024.Common Stock Shares Outstanding is likely to gain to about 5.9 M in 2024, whereas Net Loss is likely to drop (7.9 M) in 2024.
Aeterna Zentaris Workforce Comparison
Aeterna Zentaris is currently under evaluation in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 343. Aeterna Zentaris adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Aeterna Zentaris Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Aeterna Zentaris Price Series Summation is a cross summation of Aeterna Zentaris price series and its benchmark/peer.
Aeterna Zentaris Notable Stakeholders
An Aeterna Zentaris stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aeterna Zentaris often face trade-offs trying to please all of them. Aeterna Zentaris' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aeterna Zentaris' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Ward | CEO | Profile | |
| Klaus Paulini | CEO President | Profile | |
| David Dodd | Chairman, CEO and Pres | Profile | |
| Dennis Turpin | CFO, Senior Vice President | Profile | |
| Michael Teifel | Vice President - Non-Clinical Sciences | Profile | |
| Keith Santorelli | Vice President - Finance | Profile | |
| Genevieve Lemaire | Chief Accounting Officer, Vice President - Finance | Profile | |
| Richard Sachse | Senior Vice President Chief Scientific Officer, Chief Medical Officer | Profile | |
| Leslie Auld | CFO, Senior Vice President | Profile | |
| Eckhard Gunther | Vice President - Alliance Management | Profile | |
| Jeffrey Whitnell | Interim CFO | Profile | |
| James Clavijo | CFO | Profile | |
| Giuliano Fratta | Senior CFO | Profile | |
| Ginette Vallieres | Investor Relations Coordinator | Profile | |
| Jude Dinges | Chief Commercial Officer and Sr. VP | Profile | |
| Philip Theodore | Chief Admin. Officer, Sr. VP, General Counsel and Corporate Secretary | Profile | |
| Marcel Aubut | Independent Director | Profile | |
| Michael Cardiff | Director | Profile | |
| Juergen Ernst | Lead Director | Profile | |
| Pierre Lapalme | Independent Director | Profile | |
| Kenneth Newport | Director | Profile | |
| Jose Dorais | Independent Director | Profile | |
| Carolyn Egbert | Independent Director | Profile | |
| Gerard Limoges | Independent Director | Profile | |
| John Sharkey | Business Development Consultant | Profile | |
| Amlie Mtivier | Assistant Sec | Profile | |
| Eckhard Guenther | Sr Germany | Profile | |
| Matthias Gerlach | Senior Chain | Profile | |
| Nicola MD | Chief Development | Profile |
About Aeterna Zentaris Management Performance
The success or failure of an entity such as Aeterna Zentaris often depends on how effective the management is. Aeterna Zentaris management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aeterna management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aeterna management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.46) | (0.48) | |
| Return On Capital Employed | (0.57) | (0.60) | |
| Return On Assets | (0.46) | (0.48) | |
| Return On Equity | (0.93) | (0.88) |
The data published in Aeterna Zentaris' official financial statements usually reflect Aeterna Zentaris' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Aeterna Zentaris. For example, before you start analyzing numbers published by Aeterna accountants, it's critical to develop an understanding of what Aeterna Zentaris' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Aeterna Zentaris' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aeterna Zentaris' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Aeterna Zentaris' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aeterna Zentaris. Please utilize our Beneish M Score to check the likelihood of Aeterna Zentaris' management manipulating its earnings.
Aeterna Zentaris Workforce Analysis
Traditionally, organizations such as Aeterna Zentaris use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aeterna Zentaris within its industry.Aeterna Zentaris Manpower Efficiency
Return on Aeterna Zentaris Manpower
| Revenue Per Employee | 157.9K | |
| Revenue Per Executive | 157.9K | |
| Net Loss Per Employee | 581.2K | |
| Net Loss Per Executive | 581.2K | |
| Working Capital Per Employee | 1.1M | |
| Working Capital Per Executive | 1.1M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aeterna Zentaris. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Aeterna Stock please use our How to Invest in Aeterna Zentaris guide.Note that the Aeterna Zentaris information on this page should be used as a complementary analysis to other Aeterna Zentaris' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Aeterna Stock analysis
When running Aeterna Zentaris' price analysis, check to measure Aeterna Zentaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeterna Zentaris is operating at the current time. Most of Aeterna Zentaris' value examination focuses on studying past and present price action to predict the probability of Aeterna Zentaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeterna Zentaris' price. Additionally, you may evaluate how the addition of Aeterna Zentaris to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Aeterna Zentaris' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aeterna Zentaris. If investors know Aeterna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aeterna Zentaris listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.41) | Revenue Per Share 0.926 | Quarterly Revenue Growth (0.95) | Return On Assets (0.24) | Return On Equity (0.61) |
The market value of Aeterna Zentaris is measured differently than its book value, which is the value of Aeterna that is recorded on the company's balance sheet. Investors also form their own opinion of Aeterna Zentaris' value that differs from its market value or its book value, called intrinsic value, which is Aeterna Zentaris' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aeterna Zentaris' market value can be influenced by many factors that don't directly affect Aeterna Zentaris' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aeterna Zentaris' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aeterna Zentaris is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aeterna Zentaris' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.